# Satraplatin and Prednisone to Treat Prostate Cancer

> **NCT00634647** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer
- Genetic Polymorphism

## Interventions

- **DRUG:** Satraplatin
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00634647
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-19
- **Primary completion:** 2011-02-01
- **Final completion:** 2012-05-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00634647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00634647, "Satraplatin and Prednisone to Treat Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00634647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*